e-learning
resources
London 2016
Sunday, 04.09.2016
Pharmacological management of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Identification of factors associated with exacerbation risk in severe COPD: Multivariate analysis of the WISDOM study
Claus Vogelmeier (Marburg, Germany), Claus Vogelmeier, Leonardo M. Fabbri, Susan Bell, Kay Tetzlaff, Helgo Magnussen, Henrik Watz
Source:
International Congress 2016 – Pharmacological management of COPD
Session:
Pharmacological management of COPD
Session type:
Poster Discussion
Number:
302
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Claus Vogelmeier (Marburg, Germany), Claus Vogelmeier, Leonardo M. Fabbri, Susan Bell, Kay Tetzlaff, Helgo Magnussen, Henrik Watz. Identification of factors associated with exacerbation risk in severe COPD: Multivariate analysis of the WISDOM study. Eur Respir J 2016; 48: Suppl. 60, 302
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Risk factors of poor outcomes after admission for a COPD exacerbations. Multivariate logistic predictive models
Source: International Congress 2015 – COPD: interesting notes
Year: 2015
Risk factors for another hospitalization in COPD patients hospitalized for exacerbation
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016
Cardiovascular risk assessment in COPD patients with severe exacerbation
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016
Factors associated with exacerbation in a general practitioners’-based Swiss chronic obstructive pulmonary disease (COPD) cohort
Source: Annual Congress 2013 –The best posters in chronic care
Year: 2013
Predictive factors of 90-days post-discharge COPD acute exacerbation’s recurrence
Source: International Congress 2016 – In-patient and out-patient COPD management
Year: 2016
Impact of age-related comorbidities on the risk of COPD exacerbations in subjects with severe airflow limitation: A pan-European study
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
Identifying factors associated with severe asthma exacerbations: a retrospective study
Source: Eur Respir J 2007; 30: Suppl. 51, 626s
Year: 2007
Key factors associated with readmission in COPD patients
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
Baseline symptom scores and future risk of severe exacerbation: The SPARK study
Source: International Congress 2015 – New data on established treatments for asthma and COPD
Year: 2015
Frequency of COPD exacerbations and severity of COPD
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013
The frequency of COPD exacerbations is related to the comorbidity profile
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016
The CANT score: Predicting mortality in exacerbations of chronic obstructive pulmonary disease
Source: International Congress 2016 – Highlights in the management of COPD and beyond
Year: 2016
Recurrent exacerbation of asthma: Characteristics of the patients and risk factors
Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage?
Year: 2015
Characteristics and prognostic factors associated with cardiovascular (CV) comorbidity in COPD patients hospitalized for acute exacerbation (AECOPD)
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
Risk factors for severe exacerbations in asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 199s
Year: 2002
Outcome of patients following hospitalization with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) , with and without cardiovascular risk factors
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016
Clinical and demographic factors associated with pneumonia risk in a COPD patient cohort
Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice
Year: 2015
Dupilumab reduces severe exacerbations in periostin-high and periostin-low asthma patients
Source: International Congress 2016 – Asthma: from basic mechanisms to novel therapeutic perspectives
Year: 2016
Inflammatory serum profiles are consistent across independent exacerbations in COPD patients with a history of frequent exacerbations
Source: International Congress 2015 – COPD: interesting notes
Year: 2015
Usefulness of severity predictive scores in COPD exacerbations in hospitalized patients
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept